In a special episode of "Your Future Home," live from Quicken Loans' headquarters in Detroit, we take a look at the Motor City's ongoing comeback. From businesses to art, Downtown Detroit is undergoing a complete makeover.
Quicken Loans is one of the companies at the heart of Detroit's revitalization. Jay Farner, the company's CEO, explains why Quicken decided to go all-in and move its headquarters to Downtown Detroit.
One of the keys to the city's comeback is its housing market revival. Laura Grannemann, Vice President of Strategic Investments at the Quicken Loans Community Investment Fund, discusses what it takes to jump-start a struggling real estate market.
Before people packed up their things and moved to Detroit, there needed to be jobs. Dan Mullen, President at Bedrock, and Katy Cockrel, Owner of Detroit Blows, explain what it takes to bring more businesses to the area.
Plus, we'll speak to an artist that is helping give Detroit a new look. Sydney James explains why it's important for local artists to get involved in the beautification of their own neighborhoods.
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
